News

Based in Manchester, England, Mr Kelly will be responsible for introducing RainDance’s RainStorm technology platform to Europe. Mr Kelly will work with thought leaders in genomics research to

Quadramet (153 Samarium-lexidronam) is a radioactive medication that targets the bone, specifically bone cancer, and is used to treat pain caused by cancer that has metastasized or spread

According to the company, ARG201 is an immunotherapy that induces low dose oral immune tolerance in systemic scleroderma patients causing downregulation of the body’s autoimmune response. It has

In this role, Dr Fox will assume responsibility for regulatory affairs, pharmacovigilance and medical affairs. Clinical operations will continue to report to the medical director, Brett Charlton. Dr

Alsobrook comes to Exagen in 2006 as the company’s director of genomic marker discovery, responsible for quality control and analysis of genomic data using both standard statistical approaches

A special protocol assessment is intended to secure agreement on the design, size and endpoints of clinical trials that are intended to form the primary basis of an

The blinded study, conducted at seven centers across the US, included 1,831 pigmented skin lesions from 1,383 patients, making this the largest prospective study ever conducted in melanoma

Under the agreement, the Sirion sales force will promote MacuTrition and the NutriDox convenience kit and provide sampling for the TheraTears line. Barry Butler, president and CEO of

In addition to her role as CEO, Ms Laub is a member of the board of directors of Policy Studies. Previously, Ms Laub was CEO-in-residence of MML Group